APA (7th ed.) Citation

Metsemakers, S., Hermens, R., Ector, G., Blijlevens, N., & Govers, T. (2024). EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction. Value in Health, 27(6), S150. https://doi.org/10.1016/j.jval.2024.03.2271

Chicago Style (17th ed.) Citation

Metsemakers, S., RPMG Hermens, GICG Ector, NMA Blijlevens, and TM Govers. "EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction." Value in Health 27, no. 6 (2024): S150. https://doi.org/10.1016/j.jval.2024.03.2271.

MLA (9th ed.) Citation

Metsemakers, S., et al. "EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction." Value in Health, vol. 27, no. 6, 2024, p. S150, https://doi.org/10.1016/j.jval.2024.03.2271.